Q4 2023 Kymera Therapeutics Inc Earnings Call Transcript
Good morning and welcome to the Kymera Therapeutics Fourth Quarter 2023 results call. (Operator Instructions) Please not this event is being recorded. I now turn the call over to Justine Koenigsberg.
Thank you.
Good morning and welcome to Kymera's investor update. Joining me this morning are Nello Mainolfi, Founder, President and CEO; Jared Gollob, our Chief Medical Officer; and Bruce Jacobs, Chief Financial Officer. Following our prepared remarks, we will open the call to questions. We ask that you limit your questions to one and a relevant follow-up to allow enough time to address everyone's questions.
Before we begin, today's discussion will include forward-looking statements about our future expectations, plans and prospects. These statements are subject to risks and uncertainties that may cause actual results to differ materially from those projected. A description of these risks can be found in our most recent 10 K filed with the SEC. Any forward-looking statements speak only as of
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |